The
EHDS imposes Member States to develop an
opt-out possibility for
secondary use of health
data.
Opt-out means choosing not to participate in something or saying "no" to a service, activity, or use of your
data. For example, if a company sends you promotional emails, you can
opt-out to stop receiving them. In health care, it refers to the ability to decline or stop certain actions, like having your
data used for specific purposes.
GDPR and
EHDS legislation give people an easy way to
opt-out, but there is a risk to it. For example, if a company sends you promotional emails, you can
opt-out to stop receiving them. If fewer people share their
data, researchers might not have enough information to study diseases, develop treatments, and improve healthcare practices in general. Moreover, if certain groups of people opt out (e.g., specific demographics or regions), the
data may become biased. This can lead to medical findings that only apply to a narrow population and exclude underrepresented groups. Without enough
data, it becomes harder for public health organizations to track disease outbreaks and to respond to public health crises effectively. People who opt out might miss benefits, such as early disease detection or being part of cutting-edge clinical trials. Someone's health condition might go unnoticed if their
data isn’t included in population-wide screenings or analyses. While protecting privacy is critical, finding a balance between individual rights and collective benefits is essential for advancing healthcare and saving lives.
